SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-075249
Filing Date
2012-02-23
Accepted
2012-02-23 16:03:59
Documents
3
Period of Report
2012-02-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d303395d8k.htm 8-K 19091
2 CERTIFICATE OF AMENDMENT d303395dex31.htm EX-3.1 5991
3 CERTIFICATE OF ELIMINATION d303395dex32.htm EX-3.2 9903
  Complete submission text file 0001193125-12-075249.txt   36146
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 12633887
SIC: 2836 Biological Products, (No Diagnostic Substances)